Consideration of C1q and FcRn binding to allotypically disparate IgG3 could aid in engineering more efficacious anti-SARS-CoV-2 mAbs/Reply to Pandey: IgG3 allotypes, modulation of antigen binding by constant domain changes, and therapeutic applications of Fc engineering

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Proceedings of the National Academy of Sciences - PNAS 2023-05, Vol.120 (22), p.1
Hauptverfasser: Pandey, Janardan P, Izadi, Arman, Bahnan, Wael, Ohlin, Mats, Nordenfelt, Pontus
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 22
container_start_page 1
container_title Proceedings of the National Academy of Sciences - PNAS
container_volume 120
creator Pandey, Janardan P
Izadi, Arman
Bahnan, Wael
Ohlin, Mats
Nordenfelt, Pontus
description
doi_str_mv 10.1073/pnas.2306078120
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_2822495598</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2822495598</sourcerecordid><originalsourceid>FETCH-proquest_journals_28224955983</originalsourceid><addsrcrecordid>eNqNjz1PwzAQhg0CifK1sp7ESlrHSduEDUUU2FCLWCs3vqSuUtuNnSH_nouogJHJls_v8z7H2F3MxzGfJxNnpB-LhM_4PIsFP2WjmOdxNEtzfsZGnIt5lKUivWCX3u845_k046OT28IarxW2MmhrwFZQxAeQRsGiXBrYaKO0qSFYkE1jQ-90SZcelPZOUgjhrX5JoLRdo0BqBdoAmlobxHYI7m2LgFVFsVLbzhM66Gj1tFxFhf2MBOyfNn6yREdMKnmnZuwfv6HHRvQPhFFd86M4MGr8tdv0JGB8oHdQdi_JodxKUw_JYZWwpf0cdkGXIJ1rSGZA-YG1KP_6XrPzSjYeb47nFbtfPH8Ur5Fr7aFDH9Y727WGRmuRCZHm02meJf_79QXWBYlR</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2822495598</pqid></control><display><type>article</type><title>Consideration of C1q and FcRn binding to allotypically disparate IgG3 could aid in engineering more efficacious anti-SARS-CoV-2 mAbs/Reply to Pandey: IgG3 allotypes, modulation of antigen binding by constant domain changes, and therapeutic applications of Fc engineering</title><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>Free Full-Text Journals in Chemistry</source><creator>Pandey, Janardan P ; Izadi, Arman ; Bahnan, Wael ; Ohlin, Mats ; Nordenfelt, Pontus</creator><creatorcontrib>Pandey, Janardan P ; Izadi, Arman ; Bahnan, Wael ; Ohlin, Mats ; Nordenfelt, Pontus</creatorcontrib><identifier>ISSN: 0027-8424</identifier><identifier>EISSN: 1091-6490</identifier><identifier>DOI: 10.1073/pnas.2306078120</identifier><language>eng</language><publisher>Washington: National Academy of Sciences</publisher><subject>Allotypes ; Antigens ; Binding ; Immunoglobulin G ; Severe acute respiratory syndrome coronavirus 2 ; Therapeutic applications</subject><ispartof>Proceedings of the National Academy of Sciences - PNAS, 2023-05, Vol.120 (22), p.1</ispartof><rights>Copyright National Academy of Sciences May 30, 2023</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Pandey, Janardan P</creatorcontrib><creatorcontrib>Izadi, Arman</creatorcontrib><creatorcontrib>Bahnan, Wael</creatorcontrib><creatorcontrib>Ohlin, Mats</creatorcontrib><creatorcontrib>Nordenfelt, Pontus</creatorcontrib><title>Consideration of C1q and FcRn binding to allotypically disparate IgG3 could aid in engineering more efficacious anti-SARS-CoV-2 mAbs/Reply to Pandey: IgG3 allotypes, modulation of antigen binding by constant domain changes, and therapeutic applications of Fc engineering</title><title>Proceedings of the National Academy of Sciences - PNAS</title><subject>Allotypes</subject><subject>Antigens</subject><subject>Binding</subject><subject>Immunoglobulin G</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Therapeutic applications</subject><issn>0027-8424</issn><issn>1091-6490</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNqNjz1PwzAQhg0CifK1sp7ESlrHSduEDUUU2FCLWCs3vqSuUtuNnSH_nouogJHJls_v8z7H2F3MxzGfJxNnpB-LhM_4PIsFP2WjmOdxNEtzfsZGnIt5lKUivWCX3u845_k046OT28IarxW2MmhrwFZQxAeQRsGiXBrYaKO0qSFYkE1jQ-90SZcelPZOUgjhrX5JoLRdo0BqBdoAmlobxHYI7m2LgFVFsVLbzhM66Gj1tFxFhf2MBOyfNn6yREdMKnmnZuwfv6HHRvQPhFFd86M4MGr8tdv0JGB8oHdQdi_JodxKUw_JYZWwpf0cdkGXIJ1rSGZA-YG1KP_6XrPzSjYeb47nFbtfPH8Ur5Fr7aFDH9Y727WGRmuRCZHm02meJf_79QXWBYlR</recordid><startdate>20230530</startdate><enddate>20230530</enddate><creator>Pandey, Janardan P</creator><creator>Izadi, Arman</creator><creator>Bahnan, Wael</creator><creator>Ohlin, Mats</creator><creator>Nordenfelt, Pontus</creator><general>National Academy of Sciences</general><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>20230530</creationdate><title>Consideration of C1q and FcRn binding to allotypically disparate IgG3 could aid in engineering more efficacious anti-SARS-CoV-2 mAbs/Reply to Pandey: IgG3 allotypes, modulation of antigen binding by constant domain changes, and therapeutic applications of Fc engineering</title><author>Pandey, Janardan P ; Izadi, Arman ; Bahnan, Wael ; Ohlin, Mats ; Nordenfelt, Pontus</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_28224955983</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Allotypes</topic><topic>Antigens</topic><topic>Binding</topic><topic>Immunoglobulin G</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Therapeutic applications</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pandey, Janardan P</creatorcontrib><creatorcontrib>Izadi, Arman</creatorcontrib><creatorcontrib>Bahnan, Wael</creatorcontrib><creatorcontrib>Ohlin, Mats</creatorcontrib><creatorcontrib>Nordenfelt, Pontus</creatorcontrib><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pandey, Janardan P</au><au>Izadi, Arman</au><au>Bahnan, Wael</au><au>Ohlin, Mats</au><au>Nordenfelt, Pontus</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Consideration of C1q and FcRn binding to allotypically disparate IgG3 could aid in engineering more efficacious anti-SARS-CoV-2 mAbs/Reply to Pandey: IgG3 allotypes, modulation of antigen binding by constant domain changes, and therapeutic applications of Fc engineering</atitle><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle><date>2023-05-30</date><risdate>2023</risdate><volume>120</volume><issue>22</issue><spage>1</spage><pages>1-</pages><issn>0027-8424</issn><eissn>1091-6490</eissn><cop>Washington</cop><pub>National Academy of Sciences</pub><doi>10.1073/pnas.2306078120</doi></addata></record>
fulltext fulltext
identifier ISSN: 0027-8424
ispartof Proceedings of the National Academy of Sciences - PNAS, 2023-05, Vol.120 (22), p.1
issn 0027-8424
1091-6490
language eng
recordid cdi_proquest_journals_2822495598
source PubMed Central; Alma/SFX Local Collection; Free Full-Text Journals in Chemistry
subjects Allotypes
Antigens
Binding
Immunoglobulin G
Severe acute respiratory syndrome coronavirus 2
Therapeutic applications
title Consideration of C1q and FcRn binding to allotypically disparate IgG3 could aid in engineering more efficacious anti-SARS-CoV-2 mAbs/Reply to Pandey: IgG3 allotypes, modulation of antigen binding by constant domain changes, and therapeutic applications of Fc engineering
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-18T11%3A49%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Consideration%20of%20C1q%20and%20FcRn%20binding%20to%20allotypically%20disparate%20IgG3%20could%20aid%20in%20engineering%20more%20efficacious%20anti-SARS-CoV-2%20mAbs/Reply%20to%20Pandey:%20IgG3%20allotypes,%20modulation%20of%20antigen%20binding%20by%20constant%20domain%20changes,%20and%20therapeutic%20applications%20of%20Fc%20engineering&rft.jtitle=Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20-%20PNAS&rft.au=Pandey,%20Janardan%20P&rft.date=2023-05-30&rft.volume=120&rft.issue=22&rft.spage=1&rft.pages=1-&rft.issn=0027-8424&rft.eissn=1091-6490&rft_id=info:doi/10.1073/pnas.2306078120&rft_dat=%3Cproquest%3E2822495598%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2822495598&rft_id=info:pmid/&rfr_iscdi=true